GSK
Price:
$43.67
Market Cap:
$67.83B
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in we...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1980-03-28
Stock Exchange
NYSE
Ticker
GSK
According to GSK plc’s latest financial reports and current stock price. The company's current ROE is 29.50%. This represents a change of 300.09% compared to the average of 7.37% of the last 4 quarters.
The mean historical ROE of GSK plc over the last ten years is -166.87%. The current 29.50% ROE has changed -117.68% with respect to the historical average. Over the past ten years (40 quarters), GSK's ROE was at its highest in in the December 2017 quarter at 802.94%. The ROE was at its lowest in in the March 2018 quarter at -795.65%.
Average
-166.87%
Median
42.92%
Minimum
-2252.94%
Maximum
164.69%
Discovering the peaks and valleys of GSK plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 154.74%
Maximum Annual ROE = 164.69%
Minimum Annual Increase = -2876.65%
Minimum Annual ROE = -2252.94%
Year | ROE | Change |
---|---|---|
2023 | 36.92% | -20.48% |
2022 | 46.43% | 59.42% |
2021 | 29.13% | -26.10% |
2020 | 39.41% | 1.68% |
2019 | 38.76% | -53.36% |
2018 | 83.10% | -103.69% |
2017 | -2252.94% | -2876.65% |
2016 | 81.14% | -50.73% |
2015 | 164.69% | 154.74% |
2014 | 64.65% | -16.79% |
The current ROE of GSK plc (GSK) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
37.49%
5-year avg
38.13%
10-year avg
-166.87%
GSK plc’s ROE is less than Novartis AG (38.92%), less than AstraZeneca PLC (16.80%), less than Roche Holding AG (54.68%), greater than Bristol-Myers Squibb Company (-28.46%), less than Amgen Inc. (50.41%), less than Merck & Co., Inc. (33.75%), less than AbbVie Inc. (57.35%), less than Gilead Sciences, Inc. (5.21%), less than Johnson & Johnson (54.01%), less than Sanofi (10.71%), less than Biogen Inc. (7.68%),
Company | ROE | Market cap |
---|---|---|
38.92% | $228.22B | |
16.80% | $257.50B | |
54.68% | $263.51B | |
-28.46% | $98.73B | |
50.41% | $172.25B | |
33.75% | $298.70B | |
57.35% | $341.61B | |
5.21% | $98.01B | |
54.01% | $395.70B | |
10.71% | $144.70B | |
7.68% | $29.25B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GSK plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GSK plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is GSK plc's ROE?
How is the ROE calculated for GSK plc (GSK)?
What is the highest ROE for GSK plc (GSK)?
What is the 3-year average ROE for GSK plc (GSK)?
What is the 5-year average ROE for GSK plc (GSK)?
How does the current ROE for GSK plc (GSK) compare to its historical average?